Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis
The European Journal of Health Economics, 10/28/09
Punekar YS et al. – Infliximab induction regimen appears to be a cost–effective treatment option for UC patients hospitalised with an acute exacerbation.
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Pregnancy and Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/16/09
Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09
Capsule endoscopy in patients with Crohn's disease: diagnostic yield and safety
Gastrointestinal Endoscopy, 10/29/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09
Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09
Efficacy of mechanical bowel preparation with polyethylene glycol in prevention of postoperative complications in elective colorectal surgery: a meta-analysis
International Journal of Colorectal Disease, 11/24/09
Sponsor
Article Search
Sponsor


See Latest Articles


